Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
eli lilly
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
novartis
2
×
san francisco blog main
san francisco top stories
alder biopharmaceuticals
amgen
avapritinib
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
cancer
cancer drugs
capmatinib
chronic migraine
clinical trials
david rind
detroit blog main
detroit top stories
episodic migraine
eptinezumab
erenumab
europe blog main
europe top stories
fda
food and drug administration
fremanezumab
galcanezumab
gastrointestinal stromal tumors
genentech
institute for clinical and economic review
What
approval
2
×
drug
fda
medicines
2
×
address
amgen
approves
blueprint
cancer
candidates
carries
certain
class
designed
developed
genetic
gets
head
latest
migraine
new
nod
pain
pass
preventive
ret
signature
signatures
starts
targeted
targeting
therapy
won
Language
unset
Current search:
approval
×
medicines
×
novartis
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines